Determination of Voiding Patterns of Children With Vesicoureteral Reflux
This study is enrolling participants by invitation only.
Information provided by (Responsible Party):
Linda Dairiki Shortliffe, Stanford University
First received: September 13, 2005
Last updated: June 17, 2013
Last verified: June 2013
Determine if the pattern of voiding differs in children with vesicoureteral reflux (VUR) compared to those who do not have VUR.
||Time Perspective: Prospective
|Target Follow-Up Duration:
||Determination of Voiding Patterns of Children With Vesicoureteral Reflux
Primary Outcome Measures:
Secondary Outcome Measures:
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||July 2015 (Final data collection date for primary outcome measure)
We hope to determine the statistical difference between the flow rate and volume of urination in children with VUR compared to those without.
|Ages Eligible for Study:
||3 Years to 16 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Children with history of vesicoureteral reflux, toilet trained, ambulatory, and able to void on command. Children scheduled to have procedural correction of vesicoureteral reflux
- Children with or without vesicoureteral reflux (history of VUR)
- Toilet trained and can void on command
- Any voiding disorder, musculoskeletal neurologic disorders, other congenital or acquired genitourinary problems, growth disorders, recent UTI
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00186199
|Lucile Packard Childrens Hospital
|Stanford, California, United States, 94305 |
||Linda Shortliffe, MD
||Department of Urology, Stanford University
No publications provided
||Linda Dairiki Shortliffe, Professor Urology, Stanford University
History of Changes
|Other Study ID Numbers:
|Study First Received:
||September 13, 2005
||June 17, 2013
||United States: Institutional Review Board
Keywords provided by Stanford University:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on February 27, 2015
Urinary Bladder Diseases